Cognitive
Dihexa
Also called PNB-0408
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
Dihexa at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 5–20 mg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~40 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Dihexa describe 5–20 mg per administration. Descriptive only, not a recommendation.
No human pharmacokinetics; rodent work reports oral activity and metabolic stability, so this is an order-of-magnitude placeholder, not a measured value.
Evidence is preclinical: an angiotensin IV–derived peptidomimetic studied in rodent memory and neurotrophic models. No human dose-ranging study fixes an amount or schedule and the circulating figures are community-derived, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.14× single dose
- Time to steady state
- 40hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Dihexa (PNB-0408) preclinical literature (McCoy/Harding)An angiotensin IV analog reported to promote synaptogenesis via HGF/c-Met in rodent and cell models; human dosing is unpublished.